Cite
HARVARD Citation
Gatault, P. et al. (2017). Reduction of Extended‐Release Tacrolimus Dose in Low‐Immunological‐Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor‐Specific Antibodies: A Randomized Study. American journal of transplantation. 17 (5), pp. 1370-1379. [Online].